Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, International Journal of Cardiology, 6(168), p. 5323-5328

DOI: 10.1016/j.ijcard.2013.08.008

Links

Tools

Export citation

Search in Google Scholar

Clinical outcome of patients with de novo coronary bifurcation lesions treated with the Tryton Side Branch Stent. The SAFE-TRY prospective multicenter single arm study

Journal article published in 2013 by Giuseppe Tarantini, Luigi La Vecchia, Mario Galli, Luca Favero, Gianpiero D'Amico ORCID, Paolo Buja, Filippo Russo, Ester Cabianca, Massimo Napodano, Giuseppe Musumeci, Enrico Franceschini, Giuseppe Grassi, Andrea Pavei, Roberto Bonmassari, Carlo Cernetti and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

BACKGROUND: Coronary bifurcation lesions represent a difficult problem regularly confronting interventional cardiologist, in part due to the lack of dedicated device. OBJECTIVE: To investigate the feasibility, safety and effectiveness of the Tryton Side Branch Stent (Tryton Medical, Durham, NC, USA), a dedicated bare metal stent deployed in conjunction with a standard drug-eluting stent to treat bifurcation lesions. METHODS: The SAFE-TRY is a prospective single arm multicenter registry including patients with de novo bifurcation lesions in native coronary arteries and syntax score